-
GARDASIL® (Human Papillomavirus Quadrivalent [Types 6, 11, 16, 18] Vaccine, Recombinant) previously received FDA approval for prevention of cervical, vulvar, and vaginal cancer and associated precancerous lesions, and for prevention of genital warts in males and females 9-26 years of age.
-
A retrospective study was conducted of 563 children who presented over the last decade to two pediatric immunodeficiency centers in the United Kingdom.
-
ZOSTAVAX®, which had previously received FDA approval for prevention of herpes zoster (HZ) and post-herpetic neuralgia in individuals 60 years of age and older, had its approval extended to include people 50-59 years of age on March 24, 2011.
-
The story behind acetylsalicylic acid (ASA), also known as aspirin, is a fascinating one, both from its botanical origins and its modern recommendations.
-
-
A popular impression that herbs are basically safe exists along with a growing realization that some herbs interact with certain medications.
-
Fibromyalgia (FM) continues to present management challenges for patients and their physicians despite a number of new pharmaceuticals promoted for its treatment.
-
Frontal lobe dysfunction may presdispose people to have psychogenic nonepileptic seizures; this dysfunction can be measured by analyzing a brief period of the awake EEG.
-
-
The King-Devick test, if validated in future studies, has the potential of becoming a standard sideline method for identifying athletes who have sustained a brain injury.